Yungfei summary
In the LITMUS study, serum biomarkers outperformed imaging for identifying patients at risk of MASH, whereas elastography was superior for staging advanced fibrosis and cirrhosis.
Source attribution
This page contains an original Yungfei editorial summary based on publicly available entertainment coverage. The full article belongs to the original publisher.
Read full article at Nature.comKnown for
